23948sdkhjf
Log ind eller opret et abonnement for at gemme artikler
Få adgang til alt indhold på MedTechNews
Ingen binding eller kortoplysninger krævet
Gælder kun personlig abonnement.
Kontakt os for en virksomhedsløsning.
Annonce
Annonce

Fakta om udbudet

EU-nr
Offentliggjort
15.05.2025
Udbudstype
Andre

Udbyder

SYKEHUSINNKJØP HF

Intention notice: Framework agreement 2565 BCG vaccine


SYKEHUSINNKJØP HF

314573-2025 - Direct award preannouncement
Norway – Pharmaceutical products – Intention notice: Framework agreement 2565 BCG vaccine
OJ S 93/2025 15/05/2025
Voluntary ex-ante transparency notice
Supplies
1. Buyer
1.1.
Buyer
Official name SYKEHUSINNKJØP HF
2. Procedure
2.1.
Procedure
Title Intention notice: Framework agreement 2565 BCG vaccine
Description The Contracting Authority for this procurement is the Directorate for Medical Products. The Norwegian Directorate of Health is a signatory.
Procedure identifier 203ba90e-a128-4d8c-a8e6-f05263370d74
Internal identifier 2024/34128
Type of procedure Negotiated without prior call for competition
2.1.1.
Purpose
Main nature of the contract Supplies
Main classification   ( cpv ):  33600000   Pharmaceutical products
2.1.2.
Place of performance
Country Norway
Anywhere in the given country
2.1.4.
General information
Legal basis
Directive 2014/24/EU
Anskaffelsesforskriften   - Based on market surveys, there is only one supplier of BCG vaccines. The conditions for entering into a contract without a competition in accordance with the procurement regulations § 13-4 first section letter b no. 2 are thus fulfilled.
5. Lot
5.1.
Lot LOT-0000
Title Intention notice: Framework agreement 2565 BCG vaccine
Description The Contracting Authority for this procurement is the Directorate for Medical Products. The Norwegian Directorate of Health is a signatory.
Internal identifier 2024/34128
5.1.1.
Purpose
Main nature of the contract Supplies
Main classification   ( cpv ):  33600000   Pharmaceutical products
5.1.2.
Place of performance
Country Norway
Anywhere in the given country
5.1.6.
General information
The procurement is covered by the Government Procurement Agreement (GPA) yes
5.1.16.
Further information, mediation and review
Review organisation Oslo tingrett
6. Results
Direct award
Justification for direct award The contract can be provided only by a particular economic operator because of an absence of competition for technical reasons
Other justification Based on market surveys, there is only one supplier of BCG vaccines. The conditions for entering into a contract without a competition in accordance with the procurement regulations § 13-4 first section letter b no. 2 are thus fulfilled.
6.1.
Result lot ldentifier LOT-0000
6.1.2.
Information about winners
Winner
Official name AJ Vaccines
Tender
Tender identifier BCG-vaksine AJ Vaccines
Identifier of lot or group of lots LOT-0000
Contract information
Identifier of the contract Rammeavtale: 2565 BCG-vaksine
8. Organisations
8.1.
ORG-0001
Official name SYKEHUSINNKJØP HF
Registration number 916879067
Postal address Postboks 40
Town VADSØ
Postcode 9811
Country subdivision (NUTS) Finnmark   ( NO073 )
Country Norway
Contact point Postmottak Sykehusinnkjøp
Telephone +47 78950700
Internet address http://www.sykehusinnkjop.no
Roles of this organisation
Buyer
8.1.
ORG-0002
Official name AJ Vaccines
Town København
Postcode 2300
Country subdivision (NUTS) Byen København   ( DK011 )
Country Denmark
Roles of this organisation
Tenderer
Winner of these lots LOT-0000
8.1.
ORG-0003
Official name Oslo tingrett
Registration number 926725939
Town Oslo
Postcode 0125
Country subdivision (NUTS) Oslo   ( NO081 )
Country Norway
Roles of this organisation
Review organisation
Notice information
Notice identifier/version 826d47bb-1ba8-4782-a392-986aed33ca1c   -   01
Form type Direct award preannouncement
Notice type Voluntary ex-ante transparency notice
Notice subtype 25
Notice dispatch date 13/05/2025   12:41:25 (UTC) Western European Time, GMT
Notice dispatch date (eSender) 13/05/2025   12:44:06 (UTC) Western European Time, GMT
Languages in which this notice is officially available English
Notice publication number 314573-2025
OJ S issue number 93/2025
Publication date 15/05/2025
Annonce Annonce
BREAKING
{{ article.headline }}
0.031|